Pace LE, et al. - Using data from a large sample of commercially insured women, researchers assessed whether there was an increase in the use of long-acting reversible contraceptive (LARC) among commercially insured women during the 30 days following the 2016 US presidential election vs the 30 days prior to the election and the same period in 2015. Soon after the November 8, 2016, election, media and industry reports described an increase in the use of LARC methods (intrauterine devices and implants). Proposed reasons included women's concerns about access to contraceptives should the Trump Administration repeal the Patient Protection and Affordable Care Act (ACA). However, these reports were descriptive and did not control seasonal or secular trends.